OncoOne Presents Preclinical Data Update from oxMIF-targeting Pipeline at the 2023 AACR Annual Meeting
Next-generation anti-oxMIF antibody ON203 demonstrates anti-tumor effects through tumor cell death and modulation of the immunosuppressive tumor microenvironment in human tumoroids isolated from
Source: finanznachrichten.de